H.R. 10212 — PEPTIDES for Veterans Act

This section directs the Secretary of Veterans Affairs to review federal regulations and guidance on peptides, focusing on research developments since their establishment, and to establish definitions of “peptide” and “peptide-based therapy” for purposes of this Act. The Secretary must report the results, including the definitions and rationale, to Congress within 180 days of enactment.

This section requires the Secretary of Veterans Affairs to study the safety, efficacy, and therapeutic benefits of peptide-based therapies for veterans at Department of Veterans Affairs medical facilities, including applications for recovery, rehabilitation, chronic pain, mental health, and service-connected conditions. The study must be completed within 18 months after submission of the report required by section 2, with a report to Congress containing findings, recommendations, and a determination on availability; if the determination is affirmative, the Secretary must establish a pilot program limited to participating veterans, complete it within 5 years, and submit a report on effectiveness, implementation guidance, and challenges.